Genetically tailored preventive strategies: An effective plan for the twenty-first century?

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 8, 1999, Pages 649-658

  Whittemore, Alice S ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CARCINOGEN;

ARTICLE; BODY SIZE; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RESEARCH; CANCER SUSCEPTIBILITY; GENE MUTATION; GENETIC MANIPULATION; GENETIC POLYMORPHISM; HIGH RISK POPULATION; LIFESTYLE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TREATMENT PLANNING; BREAST TUMOR; CELL TRANSFORMATION; COLORECTAL TUMOR; FEMALE; FORECASTING; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MOLECULAR BIOLOGY; MUTATION; OVARY TUMOR; REVIEW; RISK ASSESSMENT;

BREAST NEOPLASMS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; FEMALE; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LIFE STYLE; MALE; MOLECULAR BIOLOGY; OVARIAN NEOPLASMS; RISK ASSESSMENT;

EID: 0033370499     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Evans, W E., Horner, M, Chu, Y. Q, Kalwinsky, D., and Roberts, W M. Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocyte leukemia. J. Pediatr., 119: 985-989, 1991
2. Chen, J., Stampfer, M J, Hough, H. L., Garcia-Closas, M, Willett, W C., Hennekens, C. H., Kelsey, K. T., and Hunter, D. J. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res. 58, 3307-3311, 1998.
3. Le Marchand, L., Wilkens, L. R., Hankin, J. H., Kolonel, L. N., and Lyu, L. C. Independent and joint effects of family history and lifestyle on colorectal cancer risk: implications for prevention. Cancer Epidemiol. Biomark. Prev., 8: 45-51, 1999.
4. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1999. CA Cancer J. Clin., 49, 8-11, 1999.
5. Mecklin, J. P., Jarvinen, H J., Hakkiluoto, A , Hallikas, H., Hiltunen, K. M., Harkonen, N., Kellokumpu, I., Laitinen, S, Ovaska, J., Tulikoura, J., and Valkamo, E. Frequency of hereditary nonpolyposis colorectalcancer. A prospective multicenter study in Finland. Dis. Colon Rectum, 38: 588-593, 1995.
6. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
7. Knudson, A. G., Jr. Mutation and cancer statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68 820-823, 1971.
8. Nathke, I. S., Adams, C. L., Polakis, P., Sellin, J. H., and Nelson, W. J. The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration J Cell Biol., 134: 165-179, 1996.
9. Barth, A. I., Nathke, I. S., and Nelson, W J. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways Curr. Opin. Cell Biol., 9: 683-690, 1997.
10. Polakis, P. The adenomatous polyposis coli (APC) tumor suppressor Biochim. Biophys. Acta, 1332: F127-F147, 1997.
11. Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R. Kinzler, K. W, Vogelstein, B., and Clevers, H. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science (Washington DC), 275: 1784-1787, 1997.
12. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC Science (Washington DC), 275: 1787-1790, 1997.
13. Peifer, M. β-Catenin as oncogene: the smoking gun. Science (Washington DC), 275: 1752-1753, 1997.
14. Aaltonen, L. A., Salovaara, R., Kristo, P., Canzian, F., Hemminki, A., Peltomaki, P, Chadwick, R. B , Kaariainen, H, Eskelinen, M., Jarvinen, H., Mecklin, J. P., and de la Chapelle, A. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N. Engl J. Med., 338: 1481-1487, 1998.
15. Kolodner, R D Mismatch repair: mechanisms and relationship to cancer susceptibility. Trends Biochem. Sci., 20: 397-401, 1995.
16. Markowitz, S, Wang, J, Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J, Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
17. Rampino, N., Yamamoto, H , Ionov, Y., Li, Y., Sawai, H . Reed, J C., and Perucho, M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype Science (Washington DC), 275: 967-969, 1997.
18. Jain, S. K., and Peppercorn, M. A. Inflammatory bowel disease and colon cancer a review. Dig. Dis., 15: 243-252, 1997.
19. Brentnall, T. A., Crispin, D. A, Rabinovitch, P. S., Haggitt, R. C, Rubin, C. E., Stevens, A. C., and Burmer, G. C. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology, 107: 369-378, 1994.
20. Aarnio, M., Mecklin, J P, Aaltonen, L. A, Nystrom-Lahti, M, and Jarvinen, H. J. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int. J. Cancer, 64: 430-433, 1995.
21. Spino, L., Olschwang, S., Groden, J , Robertson, M, Samowitz, W., Joslyn, G . Gelbert, L., Thlivens, A., Carlson, M., Otterud, B, Lynch, H., Watson, P., Lynch, P., Laurent-Puig, P., Burt, R, Hughes, J P, Thomas, G., Leppert, M., and White, R. Alleles of the APC gene: an attenuated form of familial polyposis. Cell, 75: 951-957, 1993.
22. Gayther, S. A, Wells, D., SenGupta, S. B, Chapman, P., Neale, K, Tsioupra, K., and Delhanty, J. D. Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli Hum. Mol. Genet., 3: 53-56, 1994
23. Giardiello, F. M., Petersen, G. M., Piantadosi, S., Gruber, S. B., Traboulsi, E I., Offerhaus, G J, Muro, K., Krush, A J., Booker, S. V., Luce, M C., Laken, S J, Kinzler, K. W., Vogelstein, B., and Hamilton, S. R. APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis. Gut, 40: 521-525, 1997.
24. Giardiello, F M., Krush, A J., Petersen, G M., Booker, S. V., Kerr, M., Tong, L L., and Hamilton, S. R. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology, 106: 1542-1547, 1994.
25. Potter, J. D. Colorectal cancer molecules and populations. J. Natl. Cancer Inst., 91: 916-932, 1999
26. World Cancer Research Fund Panel (J. D. Potter, Chair). Food, Nutrition, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research, 1997
27. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Controlled Clin. Trials, 19: 61-109, 1998.
28. Muscat, J E, Stellman, S. D., and Wynder, E. L. Nonsteroidal antiinflammatory drugs and colorectal cancer Cancer (Phila.), 74, 1847-1854, 1994.
29. Peleg, I. I., Maibach, H. T, Brown, S. H, and Wilcox, C. M. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch. Intern Med., 154: 394-399, 1994.
30. Suh, O, Mettlin, C., and Petrelli, N. J Aspirin use, cancer, and polyps of the large bowel. Cancer (Phila.), 72: 1171-1177, 1993.
31. Kune, G. A., Kune, S., and Watson, L. F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res., 48: 4399-4404, 1988.
32. La Vecchia, C., Negri, E., Franceschi, S., Conti, E., Montella, M., Giacosa, A., Falcini, A., and Decarli, A. Aspirin and colorectal cancer. Br. J. Cancer, 76: 675-677, 1997.
33. Rosenberg, L., Palmer, J. R., Zauber, A. G., Warshauer, M. E., Stolley, P. D., and Shapiro, S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J. Natl. Cancer Inst., 83: 355-358, 1991.
34. Rosenberg, L, Louik, C., and Shapiro, S. Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. Cancer (Phila.), 82: 2326-2333, 1998.
35. Schreinemachers, D. M., and Everson, R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology, 5: 138-146, 1994.
36. Giovannucci, E, Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., and Willett, W. C. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann. Intern. Med., 121: 241-246, 1994.
37. Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., and Speizer, F. E. Aspirin and the risk of colorectal cancer in women. N Engl. J. Med., 333: 609-614, 1995.
38. Thun, M. J., Namboodiri, M M, and Heath, C. W., Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl. J. Med, 325: 1593-1596, 1991.
39. Paganini-Hill, A, Chao, A., Ross, R. K., and Henderson, B E Aspirin use and chronic disease: a cohort study of the elderly. Br. Med. J., 299: 1247-1250, 1989
40. Gann, P. H., Manson, J. E., Glynn, R. J., Buring, J. E., and Hennekens, C. H. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J. Natl. Cancer Inst., 85: 1220-1224, 1993.
41. Greenberg, E. R., Baron, J. A., Freeman, D. H., Jr., Mandel, J. S., and Haile, R. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group J. Natl. Cancer Inst., 85: 912-916, 1993.
42. Logan, R. F, Little, J., Hawtin, P G, and Hardcastle, J. D. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br. Med. J , 307: 285-289, 1993.
43. Giardiello, F. M., Hamilton, S R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P. Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl. J. Med., 328: 1313-1316, 1993.
44. Baron, J. O., Beach, M., Mandel, J. S., van Stolk, R. U., Haile, R. W., Sandler, R. S., Rothstein, R., Summers, R. W., Snover, D. C., Beck, G. J., Bond, J. H., and Greenberg, E. R. Effect of calcium supplements on prevention of colorectal adenomas. N. Engl. J. Med, 340, 101-107, 1999
45. Swift, M, Reitnauer, P. J., Morrell, D., and Chase, C. L. Breast and other cancers in families with ataxia-telangiectasia. N. Engl. J. Med., 316: 1289-1294, 1987.
46. Chen, J., Birkholtz, G. G , Lindblom, P., Rubio, C., and Lindblom, A. The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res, 58: 1376-1379, 1998.
47. Easton, D. Ford, D., and Peto, J Inherited susceptibility to breast cancer. Cancer Surv., 18: 95-113, 1993
48. Pike, M. C., Spicer, D V., Dahmoush, L., and Press, M. F. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk Epidemiol Rev., 15 17-35, 1993
49. Bernstein, L., and Ross, R. K Endogenous hormones and breast cancer risk. Epidemiol. Rev., 15, 48-65, 1993.
50. Wu, A. H., and Pike, M C Dietary soy protein and hormonal status in females [see comment]. Am. J. Clin. Nutr., 62 151-153, 1995.
51. Hankinson, S. E., Willett, W. C., Manson, J. E., Colditz, G. A., Hunter, D. J., Spiegelman, D, Barbieri, R. L., and Speizer, F. E. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst., 90: 1292-1299, 1998.
52. Thomas, H. V., Reeves, G. K., and Key, T. J Endogenous estrogen and postmenopausal breast cancer, a quantitative review. Cancer Causes Control, 8: 922-928, 1997.
53. Wu, A. H., Pike, M. C., and Stram, D. O. Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer. J Natl. Cancer Inst., 91: 529-534, 1999.
54. Sankaranarayanan, R, and Mathew, B Retinoids as cancer-preventive agents. IARC Sci. Publ., 139: 47-59, 1996.
55. Moon, R. C. Vitamin A retinoids and breast cancer. Adv. Exp. Med. Biol., 364: 101-107, 1994.
56. Garland, M, Willett, W. C., Manson, J. E., and Hunter, D. J. Antioxidant micronutrients and breast cancer. J. Am. Coll. Nutr., 12: 400-411, 1993.
57. Hunter, D. J., and Willett, W. C. Diet, body size, and breast cancer. Epidemiol Rev, 15: 110-132, 1993.
58. Gammon, M. D., John, E. M., and Britton, J. A. Recreational and occupational physical activities and risk of breast cancer. J. Natl. Cancer Inst., 90: 100-117, 1998.
59. MacGregor, J. I., and Jordan, V. C Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev., 50: 151-196, 1998
60. Buckley, M. M., and Goa, K. L. Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs, 37: 451-490, 1989.
61. Jordan, V. C., and Murphy, C. S. Endocrine pharmacology of antiestrogens as antitumor agents. Endocr. Rev., 11: 578-610, 1990
62. Defacque, H., Piquemal, D., Basset, A., Marti, J., and Commes, T. Transforming growth factor-β1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids. J. Cell Physiol., 178: 109-119, 1999.
63. Fisher, B., Costantino, J. P., Wickerham, D L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., and Wolmark, N. Tamoxifen for prevention of breast cancer report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst., 90; 1371-1388, 1998.
64. Gail, M. H, Brinton, L. A, Byar, D. P., Code, D. K., Green, S. B., Schairer, C., and Mulvihill, J. J. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl. Cancer Inst., 81: 1879-1886, 1989
65. Delmas, P. D., Bjarnason, N. H., Mitlak, B. H., Ravoux, A C, Shah, A. S., Huster, W. J., Draper, M., and Christiansen, C Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl. J. Med., 337: 1641-1647, 1997.
66. Cummings, S. R., Browner, W. S., Bauer, D., Stone, K., Ensrud, K., Jamal, S., and Ettinger, B. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group N. Engl. J. Med., 339: 733-738, 1998.
67. Costa, A., Formelli, F , Chiesa, F., Decensi, A., De Palo, G., and Veronesi, U Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide Cancer Res., 54: 2032s-2037s, 1994.
68. Yoshizawa, M, Miyazaki, H, and Kojima, S Retinoids potentiate transforming growth factor-β activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-β receptors J. Cell Physiol., 176: 565-573, 1998
69. De Palo, G., Veronesi, U., Camerini, T., Formelli, F., Mascotti, G., Boni, C., Fosser, V, Del Vecchio, M, Campa, T., Costa, A., and Marubini, E. Can fenretinide protect women against ovarian cancer? J. Natl Cancer Inst., 87: 146-147, 1995.
70. Decensi, A., Torrisi, R., Fontana, V, Barreca, A., Ponzani, P., Pensa, F., Parodi, S., and Costa, A. Correlation between plasma transforming growth factor-β1 and second primary breast cancer in a chemoprevention trial. Eur. J. Cancer, 34, 999-1003, 1998.
71. Schrag, D., Kuntz, K. M., Garber, J. E., and Weeks, J. C. Special Report: Decision Analysis - Effects of Prophylactic Mastectomy and Oophorectomy on Life Expectancy among Women with BRCA1 or BRCA2 Mutations N. Engl. J. Med, 336: 1464-1471, 1997
72. Grann, V. R., Panageas, K. S., Whang, W., Antman, K. H., and Neugut, A. I. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J. Clin Oncol., 16: 979-985, 1998.
73. Hartmann, L. C, Schaid, D. J., Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P G, Petty, P. M., Sellers, T. A., Johnson, J L, McDonnell, S. K., Frost, M. H., and Jenkins, R B. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N. Engl. J. Med., 340: 77-84, 1999.
74. Gardner, W. U Tumongenesis in transplanted irradiated and nonirradiated ovaries. J. Natl. Cancer Inst., 26: 829-854, 1961.
75. Stadel, B. V. Letter. The etiology and prevention of ovarian cancer. Am. J. Obstet. Gynecol, 123: 772-774, 1975.
76. Risch, H. A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer Inst., 90: 1774-1786, 1998.
77. Whittemore, A. S., Gong, G., and Itnyre, J Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U. S population-based case-control studies of ovarian cancer. Am. J. Hum. Genet., 60: 496-504, 1997.
78. Stratton, J. F., Gayther, S. A., Russell P., Dearden, J., Gore, M., Blake, P., Easton, D., and Ponder, B A. Contribution of BRCA1 mutations to ovarian cancer N. Engl. J. Med., 336: 1125-1130, 1997.
79. Modan, B., Gak, E., Sade-Bruchim, R. B., Hirsh-Yechezkel, G., Theodor, L., Lubin, F., Ben-Baruch, G., Beller, U., Fishman, A., Dgani, R., Menczer, J., Papa, M., and Friedman, E. High frequency of BRCA1 185delAG mutation is ovarian cancer in Israel. National Israel Study of Ovarian Cancer. J. Am. Med. Assoc., 276: 1823-1825, 1996.
80. Easton, D F., Ford, D., and Bishop, D. T Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am. J. Hum. Genet., 56: 265-271, 1995.
81. Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., and Tucker, M. A. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med., 336: 1401-1408, 1997.
82. Weiss, N. S., Cook, L. S., Farrow, D. C., and Rosenblatt, K. A. Ovarian cancer. In: D. Schottenfeld and J. F. Fraumeni, Jr. (eds.), Cancer Epidemiology and Prevention, pp. 1040-1057. New York: Oxford University Press, 1996.
83. Cramer, D. W., Harlow, B. L., Willett, W. C., Welch, W R, Bell, D. A., Scully, R. E., Ng, W. G., and Knapp, R. C. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 2: 66-71, 1989
84. Herrinton, L. J., Weiss, N. S., Beresford, S. A., Stanford, J L., Wolfla, D. M., Feng, Z., and Scott, C. R. Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer. Am. J. Epidemiol., 141: 407-416, 1995.
85. Whittemore, A. S., Harris, R., and Itnyre, J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am. J. Epidemiol., 136: 1184-1203, 1992.
86. Narod, S. A., Risch, H., Moslehi, R., Dorum, A., Neuhausen, S., Olsson, H., Provencher, D, Radice, P., Evans, G., Bishop, S., Brunet, J. S., and Ponder, B. A. Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N. Engl. J. Med., 339, 424-428, 1998.
87. Ursin, G., Henderson, B. E., Haile, R. W., Pike, M. C., Zhou, N., Diep, A., and Bernstein, L. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? Cancer Res., 57: 3678-3681, 1997.
88. Sabichi, A. L., Hendricks, D. T, Bober, M. A., and Birrer, M. J. Retinoic acid receptor β expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide. J. Natl. Cancer Inst., 90: 597-605, 1998.
89. Tobacman, J. K., Greene, M. H., Tucker, M A., Costa, J, Kase, R, and Fraumeni, J. F., Jr. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families Lancet, 2: 795-797, 1982.
90. Piver, M. S, Jishi, M. F., Tsukada, Y., and Nava, G. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer (Phila.), 71: 2751-2755, 1993.
91. Struewing, J. P, Watson, P., Easton, D. F, Ponder, B. A., Lynch, H. T., and Tucker, M A. Prophylactic oophorectomy in inherited breast/ovarian cancer families. J Natl. Cancer Inst Mongr., 17: 33-35, 1995.
92. Claus, E. B., Risch, N., and Thompson, W D. Genetic analysis of breast cancer in the cancer and steroid hormone study Am. J Hum. Genet., 48: 232-242, 1991.